Skip to main content

Home/ Global Market Research/ Group items tagged class

Rss Feed Group items tagged

Olivia Lopez

Therapeutic Class Report Overview - Rituxan Biosimilar - 2 views

  •  
    In this report, we have analyzed the market opportunity of Rituximab Biosimilar and its competitive landscape. We believe that despite several clinical setbacks in the Rituxan biosimilars pipeline, they could pose a challenge to Rituximab by 2018.
Olivia Lopez

Therapeutic Class Overview: Treating Refractory Hematological Malignancies - 1 views

  •  
    The report provides an overview of the approved therapies for rrmm, ndmm, aml, mds, unmet need and limitations of the current soc for relapsed and refractory pts.
1 - 2 of 2
Showing 20 items per page